DR Lalchandani Labs Limited
BSE: DLCL · Healthcare Service Provider
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock DR Lalchandani Labs Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Dr. Lalchandani Labs Limited is an Indian healthcare service provider specialising in diagnostic and pathological laboratory services. The company operates a network of laboratories and collection centres, offering services ranging from routine pathology to advanced molecular diagnostics.
Business Model
The company generates revenue through a hub-and-spoke operational model, providing diagnostic services to individual patients and corporate clients. It also diversifies its income streams through healthcare consultancy and the distribution of medical equipment.
Growth Outlook
Growth is driven by the expansion of its diagnostic network within the National Capital Region and the scaling of its specialised diagnostic procedures. The firm continues to focus on providing affordable healthcare solutions to capture a larger market share.
Key Risks
- Regulatory Compliance. The diagnostic sector is subject to stringent healthcare regulations and quality standards that require continuous investment and compliance.
- Market Competition. The company faces intense competition from both large-scale diagnostic chains and numerous unorganised local players in the Indian market.
- Technological Obsolescence. Rapid advancements in diagnostic technology necessitate frequent capital expenditure to maintain service quality and competitive edge.
- Geographic Concentration. The company's heavy reliance on the National Capital Region exposes it to regional economic fluctuations and localised competitive pressures.
Start your research today
Unlock AI insights, financials, peers and live data on DR Lalchandani Labs Limited and 5,000+ companies — free.
Peers · Healthcare Service Provider
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
DR Lalchandani Labs LimitedDLCL | ₹7 Cr | — | — | — | 16.5% | — | — | -69.9% |
Krsnaa Diagnostics Ltd.KRSNAA | ₹1,830 Cr | 18.76 | 8.80 | 10.2% | 32.5% | 10.5% | 13.3% | -28.5% |
Suraksha Diagnostic Ltd.SURAKSHA | ₹1,772 Cr | 48.60 | 16.73 | 22.5% | 32.7% | 15.8% | 18.6% | +14.0% |
3B BlackBio Dx Ltd3BBLACKBIO | ₹1,237 Cr | 20.61 | 14.59 | 41.9% | 58.0% | 21.2% | 26.3% | +0.5% |
One Global Service Provider LimitedONEGLOBAL | ₹1,068 Cr | — | — | — | 19.0% | — | — | +114.9% |
Gaudium IVF and Women Health LimitedGAUDIUMIVF | ₹886 Cr | — | — | — | 36.0% | — | — | — |
As of Mar 2026
Financials
DR Lalchandani Labs Limited
BSE: DLCL · Healthcare Service Provider
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock DR Lalchandani Labs Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Dr. Lalchandani Labs Limited is an Indian healthcare service provider specialising in diagnostic and pathological laboratory services. The company operates a network of laboratories and collection centres, offering services ranging from routine pathology to advanced molecular diagnostics.
Business Model
The company generates revenue through a hub-and-spoke operational model, providing diagnostic services to individual patients and corporate clients. It also diversifies its income streams through healthcare consultancy and the distribution of medical equipment.
Growth Outlook
Growth is driven by the expansion of its diagnostic network within the National Capital Region and the scaling of its specialised diagnostic procedures. The firm continues to focus on providing affordable healthcare solutions to capture a larger market share.
Key Risks
- Regulatory Compliance. The diagnostic sector is subject to stringent healthcare regulations and quality standards that require continuous investment and compliance.
- Market Competition. The company faces intense competition from both large-scale diagnostic chains and numerous unorganised local players in the Indian market.
- Technological Obsolescence. Rapid advancements in diagnostic technology necessitate frequent capital expenditure to maintain service quality and competitive edge.
- Geographic Concentration. The company's heavy reliance on the National Capital Region exposes it to regional economic fluctuations and localised competitive pressures.
Start your research today
Unlock AI insights, financials, peers and live data on DR Lalchandani Labs Limited and 5,000+ companies — free.
Peers · Healthcare Service Provider
As of Mar 2026